A medical device called an enteroscope is used to look within the small intestine. The small intestine is reached by inserting a long, flexible tube into the mouth or rectum and guiding it through the digestive system.
A camera and a light source are included in the enteroscope, which enables medical professionals to view the small intestine’s lining and, if necessary, take samples.
Push enteroscopes and double-balloon enteroscopes are the two basic varieties. Push enteroscopes are placed through the mouth and pushed through the small intestine, whereas double-balloon enteroscopes use two balloons to help progress the scope through the small intestine.
Small intestine tumours, Crohn’s disease, celiac disease, and gastrointestinal bleeding are a few disorders that are usually diagnosed and treated by enteroscopy.
The Global Enteroscope market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
The EVIS EXERA III Double-Balloon Endoscope System from Olympus was launched. This is a new version of the double-balloon enteroscope system made by the business, and it is intended to offer superior manoeuvrability and high-quality imaging for the detection and treatment of small intestinal problems.
The EVIS EXERA III system has a number of cutting-edge features, including a high-definition imaging system, an upgraded balloon design for greater grip and control, and improved suction for effective mucosal cleaning.
In order to enable numerous diagnostic and therapeutic operations, it also comes with a variety of appropriate attachments, like biopsy forceps and stents.
The EVIS EXERA III system, which Olympus has positioned as a significant development in enteroscopy technology, gives clinicians better visualisation and navigation capabilities to aid in the diagnosis and treatment of a variety of gastrointestinal disorders, including small bowel tumours, inflammatory bowel disease, and obfuscated gastrointestinal bleeding.
© Copyright 2017-2023. Mobility Foresights. All Rights Reserved.